Press Release / Sep 19, 2024
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Commitment to partnership and joint innovation for cell and gene therapies
Executiva, 23 February 2026
Hovione is Growing
Hovione commitment to setting SBTs in line with the Paris Agreement
EY Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.
Innovations in Pharmaceutical Technology, IPT Online, 27 October 2025